Evidence map›Paper›PMID 38150333›Full record

ArticleACS chemical neuroscience2024

Development of 2-Aminotetralin-Type Serotonin 5-HT

Ryan P McGlynn, Meng Cui, Brittany Brems, Otto Holbrook, Raymond G Booth

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS chemical neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Pharmacologic MRI Brain Imaging Studies of Serotonin 5-HTPharmacology research & perspectives · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ryan P McGlynnCenter for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States.ORCID 0000-0001-9293-5441
Meng CuiCenter for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States.ORCID 0000-0002-3895-135X
Brittany BremsCenter for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States.
Otto HolbrookCenter for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States.
Raymond G BoothCenter for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States.
Northeastern University · US

Funding

Delineating the role of serotonin 5-HT2 receptors in opioid use disorders:Development of novel 5-HT2 modulators with translational studies in rodents andprimatesR01DA047130 · NIDA · NORTHEASTERN UNIVERSITY · PI BOOTH, RAYMOND G., KOHUT, STEPHEN JOHN · 2018 to 2022
$3.2M
Serotonin 5HT2C Agonist Drugs with 5HT2A/2B Antagonist ActivityR01MH081193 · NIMH · UNIVERSITY OF FLORIDA · PI BOOTH, RAYMOND G. · 2008 to 2012
$1.8M
Training Program on Development of Medications for Substance Use DisorderT32DA055553 · NIDA · NORTHEASTERN UNIVERSITY · PI Raymond G. Booth, Alexandros Makriyannis · 2022 to 2026
$1.3M
NIDA NIH HHS R01 DA047130NIDA NIH HHS T32 DA055553NIMH NIH HHS R01 MH081193
6 · The paper itself

Abstract

The serotonin (5-hydroxytryptamine, 5-HT) 5-HT

Indexed as

Receptor, Serotonin, 5-HT1FSerotoninTetrahydronaphthalenesLigandsReceptor, Serotonin, 5-HT1BReceptors, SerotoninReceptors, Serotonin, 5-HT1Serotonin Receptor Agonists2-aminotetralinLigandsReceptor, Serotonin, 5-HT1BReceptor, Serotonin, 5-HT1FReceptors, SerotoninReceptors, Serotonin, 5-HT1SerotoninSerotonin Receptor AgonistsTetrahydronaphthalenesaminotetralinmolecular modelingserotonin receptorsstructure activity relationships

Identifiers

PMID38150333
PMCPMC10797628
OpenAlexW4390265017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.